SMTL ID : 9cw4.1 (1 other biounit)

Structure of human endothelial nitric oxide synthase heme domain bound with 6-(3-fluoro-5-((methylamino)methyl)phenyl)-4-methylpyridin-2-amine dihydrochloride

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

homo-dimer

Ligands

2 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)

HEM.1: 18 residues within 4Å: Chain A: W.138, A.141, R.143, C.144, S.186, M.299, F.313, S.314, G.315, W.316, M.318, E.321, V.378, W.407, F.433, Y.435 Ligands: H4B.2, 01.3 17 PLIP interactions: 17 interactions with chain A, Hydrophobic interactions: A:W.138, A:W.138, A:A.141, A:F.313, A:F.313, A:F.313, A:W.316, A:E.321, A:V.378, A:W.407, A:W.407, A:F.433 Hydrogen bonds: A:Y.435 Water bridges: A:R.325 Salt bridges: A:R.143 pi-Stacking: A:W.138 Metal complexes: A:C.144 HEM.13: 20 residues within 4Å: Chain B: W.138, A.141, R.143, C.144, V.145, G.146, S.186, M.299, F.313, S.314, G.315, W.316, M.318, E.321, V.378, W.407, F.433, Y.435 Ligands: H4B.14, 01.15 19 PLIP interactions: 19 interactions with chain B, Hydrophobic interactions: B:W.138, B:W.138, B:W.138, B:W.138, B:A.141, B:F.313, B:F.313, B:F.313, B:W.316, B:E.321, B:V.378, B:F.433, B:F.433 Water bridges: B:E.321, B:E.321, B:R.325 Salt bridges: B:R.143 pi-Stacking: B:W.138 Metal complexes: B:C.144

2 x H4B: 5,6,7,8-TETRAHYDROBIOPTERIN(Non-covalent)

H4B.2: 11 residues within 4Å: Chain A: S.62, V.64, R.325, A.406, W.407 Chain B: W.405, F.420, H.421, Q.422, E.423 Ligands: HEM.1 9 PLIP interactions: 1 interactions with chain B, 8 interactions with chain A Hydrophobic interactions: B:E.423 Hydrogen bonds: A:R.325, A:R.325, A:A.406, A:W.407 pi-Stacking: A:W.407, A:W.407 pi-Cation interactions: A:W.407, A:W.407 H4B.14: 12 residues within 4Å: Chain A: W.34, W.405, F.420, H.421, Q.422, E.423 Chain B: S.62, V.64, R.325, A.406, W.407 Ligands: HEM.13 9 PLIP interactions: 2 interactions with chain A, 7 interactions with chain B Hydrophobic interactions: A:E.423 Hydrogen bonds: A:H.421, B:R.325, B:R.325, B:A.406, B:W.407 pi-Stacking: B:W.407, B:W.407 pi-Cation interactions: B:W.407

2 x 01: (6M)-6-{3-fluoro-5-[(methylamino)methyl]phenyl}-4-methylpyridin-2-amine

01.3: 13 residues within 4Å: Chain A: Q.207, P.294, V.296, N.298, F.313, S.314, G.315, W.316, Y.317, M.318, E.321 Ligands: HEM.1, CL.9 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:P.294, A:V.296, A:F.313 Hydrogen bonds: A:M.318, A:E.321 01.15: 14 residues within 4Å: Chain B: Q.207, P.294, V.296, N.298, M.299, F.313, S.314, G.315, W.316, Y.317, M.318, E.321 Ligands: HEM.13, CL.18 5 PLIP interactions: 5 interactions with chain B Hydrophobic interactions: B:P.294, B:V.296, B:F.313 Hydrogen bonds: B:M.318, B:E.321

6 x BTB: 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-covalent)

BTB.4: 5 residues within 4Å: Chain A: W.282, V.341, C.342, D.344 Ligands: GD3.10 1 PLIP interactions: 1 interactions with chain A Salt bridges: A:D.344 BTB.5: 3 residues within 4Å: Chain A: E.337, T.347, R.348 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:E.337, A:E.337, A:T.347 BTB.6: 3 residues within 4Å: Chain A: D.257, E.258, P.259 1 PLIP interactions: 1 interactions with chain A Salt bridges: A:E.258 BTB.16: 3 residues within 4Å: Chain B: T.279, E.281 Ligands: GD3.19 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:E.281 Salt bridges: B:E.281 BTB.17: 2 residues within 4Å: Chain B: D.257, E.258 1 PLIP interactions: 1 interactions with chain B Salt bridges: B:E.258 BTB.20: 1 residues within 4Å: Chain B: D.344 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:D.344 Salt bridges: B:D.344

3 x GOL: GLYCEROL(Non-functional Binders)

GOL.7: 1 residues within 4Å: Chain A: E.127 No protein-ligand interaction detected (PLIP) GOL.8: 1 residues within 4Å: Chain A: Q.217 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:Q.217 GOL.12: 2 residues within 4Å: Chain A: D.344, L.345 No protein-ligand interaction detected (PLIP)

2 x CL: CHLORIDE ION(Non-functional Binders)

CL.9: 5 residues within 4Å: Chain A: Q.207, Y.291, Y.317, N.326 Ligands: 01.3 Ligand excluded by PLIP CL.18: 5 residues within 4Å: Chain B: Q.207, Y.291, Y.317, N.326 Ligands: 01.15 Ligand excluded by PLIP

2 x GD3: GADOLINIUM ION(Non-functional Binders)(Non-covalent)

GD3.10: 1 residues within 4Å: Ligands: BTB.4 No protein-ligand interaction detected (PLIP) GD3.19: 3 residues within 4Å: Chain B: T.279, E.281 Ligands: BTB.16 3 PLIP interactions: 2 interactions with chain B, 1 Ligand-Water interactions Metal complexes: B:T.279, B:E.281, H2O.4

1 x ZN: ZINC ION(Non-covalent)

ZN.11: 4 residues within 4Å: Chain A: C.54, C.59 Chain B: C.54, C.59 4 PLIP interactions: 2 interactions with chain B, 2 interactions with chain A Metal complexes: B:C.54, B:C.59, A:C.54, A:C.59

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Vasu, D. et al., Truncated pyridinylbenzylamines: Potent, selective, and highly membrane permeable inhibitors of human neuronal nitric oxide synthase. Bioorg.Med.Chem. (2025)

Release Date

2025-04-30

Peptides

Nitric oxide synthase, endothelial: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Nitric oxide synthase, endothelial

Related Entries With Identical Sequence